首页> 外文期刊>Clinical otolaryngology: official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery >Bell's palsy - the effect of prednisolone and/or valaciclovir versus placebo in relation to baseline severity in a randomised controlled trial
【24h】

Bell's palsy - the effect of prednisolone and/or valaciclovir versus placebo in relation to baseline severity in a randomised controlled trial

机译:贝尔麻痹-泼尼松龙和/或伐昔洛韦与安慰剂的作用与基线严重程度的随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: To evaluate the treatment effect of prednisolone and/or valaciclovir in Bell's palsy patients with different baseline severity of palsy. Design: Patient data were collected from the Scandinavian Bell's Palsy Study, a prospective, randomised, double-blind, placebo-controlled, multi-centre trial. Setting: Sixteen otorhinolaryngological centres in Sweden and one in Finland. Participants: Altogether, 829 patients aged 18-75years were treated within 72h of palsy onset. Patients were randomly assigned to treatment with prednisolone plus placebo (n=210), valaciclovir plus placebo (n=207), prednisolone plus valaciclovir (n=206), placebo plus placebo (n=206). Follow-up was 12months. Main outcome measures: Facial function was assessed using the Sunnybrook grading scale at baseline and at 12months. Complete recovery was defined as Sunnybrook score=100. Results: All patients, regardless of baseline severity, showed significantly higher complete recovery rates if treated with prednisolone compared with no prednisolone. In patients with severe palsy, recovery at 12months was 51% with prednisolone treatment versus 31% without prednisolone (P=0.02). Corresponding results were 68%versus 51% (P=0.004) for moderate, and 83%versus 73% (P=0.02) for mild palsy. In patient groups with moderate and mild palsy at baseline, significantly fewer prednisolone-treated patients had synkinesis at 12months (P=0.04 and P<0.0001, respectively). For patients with severe palsy at baseline, prednisolone versus no prednisolone made no significant difference regarding synkinesis at 12months. Valaciclovir did not add any significant effect to prednisolone regarding recovery rate or synkinesis at 12months. Conclusion: Prednisolone treatment resulted in higher complete recovery rates, regardless of severity at baseline. Prednisolone treatment should be considered in all patients irrespective of degree of palsy.
机译:目的:评价泼尼松龙和/或伐昔洛韦在贝尔严重性基线不同的麻痹患者中的治疗效果。设计:患者数据来自斯堪的纳维亚贝尔的麻痹研究,这是一项前瞻性,随机,双盲,安慰剂对照的多中心试验。地点:瑞典有16个耳鼻咽喉科中心,芬兰有1个。参与者:共有829名18-75岁的患者在麻痹发作后72小时内接受了治疗。患者被随机分配接受泼尼松龙加安慰剂(n = 210),伐昔洛韦加安慰剂(n = 207),泼尼松龙加伐昔洛韦(n = 206),安慰剂加安慰剂(n = 206)治疗。随访12个月。主要结局指标:在基线和第12个月使用Sunnybrook分级量表评估面部功能。完全恢复定义为Sunnybrook得分= 100。结果:与泼尼松龙相比,所有患者,无论基线严重程度如何,如果使用泼尼松龙治疗,均显示出明显更高的完全恢复率。在重度麻痹的患者中,泼尼松龙治疗12个月的恢复率为51%,而泼尼松龙的治疗为31%(P = 0.02)。相应的结果是中度麻痹68%vs 51%(P = 0.004),轻度麻痹83%vs 73%(P = 0.02)。在基线时出现中度和轻度麻痹的患者组中,泼尼松龙治疗的患者在12个月时发生突触的情况明显减少(分别为P = 0.04和P <0.0001)。对于基线时出现严重麻痹的患者,泼尼松龙与没有泼尼松龙在12个月时的突触作用没有显着差异。在12个月时,伐昔洛韦对泼尼松龙的恢复率或突触没有明显影响。结论:泼尼松龙治疗导致更高的完全恢复率,而与基线时的严重程度无关。所有患者均应考虑泼尼松龙的治疗,无论其麻痹程度如何。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号